Filling the need for trusted information on health issues…

Trending on kff Enrollment Marketplaces Medicare Advantage

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Cholera Epidemic In Haiti Persists Despite Slowdown In Fatalities

“A multinational medical response has slowed deaths in a Haitian cholera epidemic that has killed more than 250 people so far, but the outbreak is likely to widen, a senior U.N. official said on Sunday,” Reuters reports. The U.N., Haitian government and aid partners “have launched a major effort to try to contain the epidemic” of more than 3,000 cases in the country so far (Delva, 10/25). The New York Times reports that the death rate, according to the Haitian government, has “declined – from 10.6 percent of known cases three days earlier to 8.2 percent now.”

PhRMA Representatives Meet With Officials In India To Discuss Compulsory Licensing

During a visit with government officials, industry leaders and NGOs in India last week, representatives from Pharmaceutical Research and Manufacturers of America (PhRMA), a U.S. lobbying group that represents the country’s pharmaceutical industry and biotechnology companies, addressed “the Indian government’s proposal to allow local drugmakers to make low-cost version of patented drugs so that they can be made available to patients,” the Economic Times reports. “Issuing compulsory licensing is not a long-term solution and will be counterproductive,” PhRMA Executive VP Christopher Singer said.

Also In Global Health News: Foreign Aid In Ethiopia; Elizabeth Glaser Pediatric AIDS Foundation; Health In Myanmar; Poverty In Zambia; Rwanda’s Progress on MDGs; Men Involved In PMTCT Of HIV

Ethiopian Government Restricting Opponents’ Access To Development Aid, Report Says Ethiopia’s government has been restricting access to food and other types of foreign aid among opposition supporters, Human Rights Watch (HRW) said in a report on Tuesday, Reuters reports (Malone, 10/19). The report is based on more than 200 interviews, conducted over…

Financing HIV/AIDS Prevention, Treatment Could Cost $400B-$700B Over 20 Years

A new report published by the Results for Development Institute in the Lancet “has offered governments and donors a glimpse into the future of HIV epidemics – and what it will cost to prevent and treat them. Researchers warn of hard choices ahead and a need for some countries to take more responsibility for their national programmes, IRIN/PlusNews reports. Study authors present their “cheapest” and “ideal” scenarios for HIV funding in the future, according to IRIN/PlusNews.

Miller-McCune Examines Impact Of Limited Access To Schistosomiasis Drug In Africa

Miller-McCune examines the limited access populations living in Africa have to the schistosomiasis drug praziquantel – “the only commercially available treatment for the disease.” Schistosomiasis “kills about 300,000 people and afflicts more than 200 million yearly with chronic and severe anemia, abdominal pain, diarrhea, infertility and bladder cancer,” the magazine writes, adding that the disease is “[e]specially prevalent in sub-Saharan Africa, [where] by some estimates, nearly 800 million people are at risk of infection.”